To: dr_elis who wrote (18899 ) 6/15/1999 6:18:00 PM From: shane forbes Respond to of 25814
No can do. When I get to 100 (a double entendre) or bored first. Right now I am having too much fun. Mr. Twit comes up with his great announcements of something bogus and his great criticisms and bang he is wrong. In fact I have found the harsher and more grandiose the rhetoric directed towards me the more likely I am to find some big piece of crappola in his posts (like 2.5%, 1.85b, pooling accounting, new average of 2.07b, 9%, disservice to shareholders and the public in general (for Pete's sake!) and on and on - its just way way too easy!) The inner adult is what condemns people to having too high a regard for money in one's blood and to living a false unfulfilled life. HA HA HA HA HA ... Psyche -10101010101010101... Quite proud to be childish... and young. 84 or 83 to go... Feel free to skip and fast forward. Play may still be boring 2 months from now. -- ending song: Repeat 16-- 'The base revenues for LSI were $1.85 billion in 1998. Except for a IPR&D accounting writeoff (bogus), the Symbios assets that LSI bought were not subsequently written off. What did take place was a $5.4 million Symbios Integration Accrual. Per the 10-K, page 42, this accrual comprised '$4 million related to involuntary separation and relocation benefits for approximately 300 Symbios positions and $1.4 million in other exit costs primarily relating to the closing of Symbios sales offices and the termination of certain contractual relationships.' Therefore it appears that the $75 mil restructuring charge taken later was for the 'old LSI' and has very little negative bearing on Symbios continuing operations. LSI valued Symbios at a fair value of $804 million - $324 million for tangible assets, $214 million for current technology, $37 million for assembled workforce and trademarks, $83 million for goodwill, and $146 million for IPR&D (this part was written off). In this context, $5.4 million is puny and irrelevant. Symbios' assets (read: ability to generate revenue) only strengthened after integration with LSI. They did not weaken. Further, LSI has not indicated that they discontinued anything significant in the Symbios product line. Because they used purchase accounting (versus pooling) LSI can't use pro-forma Q1, Q2, Q3 or full-year 1998 numbers going forward. It is NOT because, as Jock mumbles grandiosely: "It would be a terrible disservice to the company, shareholders, and the public in general.". Give me a freakin' break.' ---